The pharmaceutical sector in India presents a intricate landscape, increasingly marked by concerns surrounding dominance . While the nation boasts a vibrant generic sector , a few significant companies maintain a substantial portion of the market , sparking questions about rivalry and consumer access to accessible drugs . This situation is fueled b

The global pharmaceutical industry is dominated by a handful of large corporations that exert considerable influence over drug prices and availability. These giants control vast research and development|R&D|clinical trials budgets, allowing them to outpace rivals in the development of new medications. The result is often high treatment costs|medica